ETF Managers Group’s AtriCure ATRC Stock Holding History

ETF Managers Group’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,132	Closed	-$883K	–	677
2021 Q2	$883K	Buy	+11,132	New	+$809K	0.01%	282

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ETF Managers Group's ATRC Position: Q3 2021 in Review

ETF Managers Group sold out of AtriCure (ATRC) in Q3 2021, closing a stake of 11,132 shares — an estimated $883K sold.

ETF Managers Group first reported a position in ATRC in Q2 2021 and held it in 1 quarter. The position peaked at $883K in Q2 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q3 2021.

ETF Managers Group reported no remaining AtriCure position as of Q3 2021 after selling out during the quarter.
ETF Managers Group sold 11,132 AtriCure shares in Q3 2021, an estimated $883K.
ETF Managers Group first reported a position in AtriCure in Q2 2021 and held it in 1 quarter.
ETF Managers Group's AtriCure position peaked at $883K in Q2 2021.
213 funds tracked by Wall St. Rank held AtriCure as of Q3 2021.

Based on ETF Managers Group's 13F filing for Q3 2021, filed 15 Nov 2021.